How much muscle do you lose on a GLP-1, and can you protect it?

Written and medically reviewed by Zahraa Sater, M.D., M.P.H.

Reviewed August 12, 2026 · Next review due August 12, 2027

Short answer

Roughly a quarter to 40 percent of the weight lost on a GLP-1 is lean tissue, which is similar to what happens with any rapid weight loss. In the STEP 1 body composition substudy, fat mass fell 19.3 percent and lean body mass fell 9.7 percent, so lean mass rose as a proportion of body weight. Protein and resistance training are the defences.

Every method of losing weight costs some lean tissue. The question is how much, and whether the proportion is worse on a GLP-1 than on any other route to the same weight loss. The honest answer from the body composition data is that it is not obviously worse, but the absolute loss is larger simply because the total weight loss is larger.

What the body composition substudies found

In the STEP 1 DXA substudy of 140 participants, semaglutide produced a 15.0 percent reduction in body weight, a 19.3 percent reduction in total fat mass, a 27.4 percent reduction in visceral fat, and a 9.7 percent reduction in lean body mass. Because fat fell faster than lean tissue, lean mass rose by 3.0 percentage points as a share of total body weight. Expressed the other way round, about 39 percent of the weight lost in STEP 1 was lean mass. The SURMOUNT-1 body composition analysis of tirzepatide put the lean fraction at about 25 percent. Both figures sit inside the range reported for diet-induced weight loss.

Why this still matters clinically

Lean mass is not only muscle: it includes organ tissue, connective tissue and body water, and some reduction is appropriate when a body gets smaller. What matters is function and reserve. A 62 year old losing 22 kg has a different margin for error than a 32 year old losing the same amount, and older adults, women after menopause and anyone already deconditioned have the least to spare. Grip strength, stair climbing and the ability to get out of a chair without hands are more informative than any scan.

What actually protects lean mass

The 2025 joint advisory from the American College of Lifestyle Medicine, the American Society for Nutrition, the Obesity Medicine Association and The Obesity Society proposed a protein target of 1.2 to 1.6 g/kg per day during active weight loss, well above the 0.8 g/kg general population figure, together with strength training at least three times a week and at least 150 minutes of aerobic activity. That combination is the only intervention with a plausible evidence base. No supplement, peptide or amino acid product has been shown to substitute for it.

Set a protein target in grams before you escalate the dose, put two or three resistance sessions in the diary, and get a baseline measure you can repeat, whether that is a DEXA scan, a bioimpedance reading taken under the same conditions each time, or a simple grip strength and sit to stand test. Losing weight without knowing what tissue is leaving is the avoidable part of this.

The clinical detail

STEP 1 body composition substudy, n=140, DXA at baseline and week 68: total body weight minus 15.0 percent, total fat mass minus 19.3 percent, visceral fat mass minus 27.4 percent, lean body mass minus 9.7 percent, with lean mass increasing 3.0 percentage points as a proportion of total mass. Improvement in the lean to fat ratio was greater in those achieving 15 percent or more weight loss. Reported lean fraction of total weight lost is approximately 39 percent in STEP 1 and approximately 25 percent in the SURMOUNT-1 analysis. Joint advisory targets: protein 1.2 to 1.6 g/kg per day during active weight reduction, resistance training three or more sessions weekly, aerobic activity 150 minutes or more weekly. The advisory notes uncertainty about whether the protein target should be based on actual, adjusted or fat-free body weight.

Written and medically reviewed by Zahraa Sater, M.D., M.P.H.

Reviewed August 12, 2026 · Next review due August 12, 2027

Sources

  1. Impact of Semaglutide on Body Composition in Adults With Overweight or Obesity: Exploratory Analysis of the STEP 1 Study. Journal of the Endocrine Society. doi:10.1210/jendso/bvab048.030
  2. Nutritional Priorities to Support GLP-1 Therapy for Obesity: a joint Advisory. American Journal of Clinical Nutrition
  3. Muscle matters: the challenge of preserving lean mass during obesity treatment. Healio Endocrine Today
  4. Prescription Medications to Treat Overweight and Obesity. NIDDK, National Institutes of Health

Was this answer helpful?

This library is educational and is not individual medical advice. Read our Editorial and Medical Review Policy.